Retail sale of pharmaceutical products
FARMACARE HOLDING AS
Revenue 2025
NOK 0
Operating profit
NOK −16,000
Equity
NOK −7,000
Incorporated
2021
Share capital
NOK 30,000
Key figures · 2025
Equity ratio
-2.4%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -5.2% | |
| Likviditet | ||
| Working capital | 7k | |
| Soliditet | ||
| Equity ratio (%%) | -2.4% | |
| Debt-to-equity ratio | -43.33 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.